GXE:ETR
Lakefront Biotherapeutics NV
၂၆.၆၂ €
arrow_downward
-၁.၁၁%(-၀.၃၀) 1D
အောက် ၁၆, GMT+၂ ၁၃:၁၇:၅၀ · EUR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for GXE...
Open
၂၆.၇၆ €
High
၂၆.၇၆ €
Low
၂၆.၆၂ €
Mkt. cap
၁၇၅.၁၅ ဋေ
Avg. vol.
၆၂၁.၀၀
Volume
၁.၀၀
P/E ratio
၂.၉၄
52-wk high
၃၀.၀၂ €
52-wk low
၂၂.၈၄ €
EPS
၉.၀၅ €
No. of employees
၁၉၆
Open
၂၆.၇၆ €
High
၂၆.၇၆ €
Low
၂၆.၆၂ €
Mkt. cap
၁၇၅.၁၅ ဋေ
Avg. vol.
၆၂၁.၀၀
Volume
၁.၀၀
P/E ratio
၂.၉၄
52-wk high
၃၀.၀၂ €
52-wk low
၂၂.၈၄ €
EPS
၉.၀၅ €
No. of employees
၁၉၆
News stories
From web sources and news partners
BioSpace
·
ပြီးခဲ့သည့် ၂၁ နာရီ
Stoffels strikes up new biotech in return to Galapagos cell therapy mission
Profile
Lakefront Biotherapeutics is a Belgian pharmaceutical research company which was founded in 1999. Its headquarters are located in Mechelen and has additional locations in Leiden, Romainville, Basel, Milan, Madrid, Boston and Zagreb.
The company develops drugs against rheumatoid arthritis, Crohn's disease, ulcerative colitis, psoriasis, systemic lupus erythematosus and cystic fibrosis. Wikipedia
About Lakefront Biotherapeutics NV